Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion in the treatment of adult ADHD
IRCT201302201556N51Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bupropion in attention deficit hyperactivity disorder (ADHD), sponsored by Tehran University of Medical Sciences. Started Apr 2013; status: completed.
02
Drugs
bupropion
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT201302201556N51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201302201556N51.